Patients with stage 1 or 2, hormone receptor (HR)-negative breast cancer had similar five-year rates of locoregional recurrence whether or not they underwent preoperative breast magnetic resonance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback